Immediate Impact
15 standout
Citing Papers
Epigenetics-targeted drugs: current paradigms and future challenges
2024 Standout
Current and future immunotherapeutic approaches in pancreatic cancer treatment
2024 Standout
Works of Sarah Wall being referenced
A Phase I Clinical Trial Testing the Safety of IL-21-Expanded, Universally Alloreactive Donor-Derived Natural Killer Cells for Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome
2021
Characterizing inclusion and exclusion criteria in clinical trials for chimeric antigen receptor (CAR) T-cell therapy among adults with hematologic malignancies
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Sarah Wall | 87 | 75 | 30 | 58 | 52 | 229 | |
| Najla El Jurdi | 109 | 72 | 31 | 19 | 49 | 221 | |
| Yeon Jung Lim | 63 | 36 | 40 | 21 | 36 | 270 | |
| Sachin Punatar | 82 | 49 | 29 | 44 | 58 | 220 | |
| Nina Rosa Neuendorff | 115 | 68 | 38 | 60 | 28 | 246 | |
| Ignacio Gómez‐Centurión | 101 | 79 | 25 | 20 | 27 | 216 | |
| Avinash Bonda | 57 | 70 | 18 | 31 | 44 | 181 | |
| Lingaraj Nayak | 62 | 77 | 18 | 45 | 60 | 190 | |
| Anant Gokarn | 66 | 70 | 23 | 42 | 58 | 265 | |
| Katie S. Gatwood | 78 | 104 | 37 | 22 | 31 | 237 | |
| William J. Baker | 77 | 28 | 21 | 13 | 30 | 283 |
All Works
Login with ORCID to disown or claim papers
Loading papers...